STREPTOZOCIN

230 reported adverse events

Drug classes: Alkylating Drug [EPC]

These side effects are most commonly reported by patients taking STREPTOZOCIN:

# Side effect Count
0 MALIGNANT NEOPLASM PROGRESSION 63
1 PRODUCT USE IN UNAPPROVED INDICATION 40
2 PANCREATIC NEUROENDOCRINE TUMOUR 37
3 DRUG INEFFECTIVE 35
4 HYPOGLYCAEMIA 35
5 FATIGUE 34
6 NAUSEA 29
7 OFF LABEL USE 28
8 DISEASE PROGRESSION 24
9 DECREASED APPETITE 23
See all common reactions for STREPTOZOCIN

STREPTOZOCIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC NEOPLASM MALIGNANT NON-RESECTABLE 1 0.0588
1 PANCREATIC NEUROENDOCRINE TUMOUR 37 0.0577
2 CLONAL EVOLUTION 4 0.0385
3 PORTAL VEIN EMBOLISM 1 0.0385
4 BLOOD GLUCAGON INCREASED 1 0.0217
5 SMALL INTESTINE NEUROENDOCRINE TUMOUR 1 0.0182
6 RETROPERITONEAL CANCER 1 0.0125
7 BLOOD CHROMOGRANIN A INCREASED 5 0.0109
8 TUMOUR NECROSIS 10 0.0095
9 GASTRIC ANTRAL VASCULAR ECTASIA 5 0.0095
See all enriched reactions for STREPTOZOCIN